Patient preferences and satisfaction in the treatment of rheumatoid arthritis with biologic therapy

Abstract

Patient preferences and satisfaction in the treatment of rheumatoid arthritis with biologic therapy Jennifer L BartonDivision of Rheumatology, University of California San Francisco, San Francisco, California, USA Significant advances in the treatment of rheumatoid arthritis (RA) have been made over the past 10 years with the introduction of biologic therapies, such as the TNF inhibitors. With these medications, many patients with RA have seen significant improvement in symptoms, function, and quality of life. However, with the introduction of the biologics, decision-making for this chronic disease that affects up to 1% of the population has become even more complex. Patient preferences for mode and frequency of administration, and for certain risks vs benefits as well as medication beliefs are central to uptake and adherence to these medications. This review examines the current literature on patient satisfaction, adherence, and preference for biologic therapy in RA.Keywords: rheumatoid arthritis, patient preference, adherence, biologics